Insmed, Inc.
(NASDAQ : INSM)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 1.35%165.400.7%$1348.59m
LLYEli Lilly & Co. 0.83%324.231.1%$1076.59m
ABBVAbbVie, Inc. 1.85%140.881.9%$868.03m
PFEPfizer Inc. 0.65%44.430.9%$803.40m
BMYBristol-Myers Squibb Co. 1.08%71.291.0%$780.99m
MRKMerck & Co., Inc. 0.69%88.150.7%$715.24m
AZNAstraZeneca Plc 2.21%56.781.0%$396.07m
ALNYAlnylam Pharmaceuticals, Inc. -1.18%194.478.2%$214.83m
GSKGSK Plc 2.20%30.920.3%$214.29m
NVSNovartis AG 2.20%78.360.2%$206.10m
GBTGlobal Blood Therapeutics, Inc. 0.00%68.485.4%$191.16m
IDXXIDEXX Laboratories, Inc. 3.65%348.983.9%$191.02m
HZNPHorizon Therapeutics Plc 1.70%65.355.4%$176.59m
ATXIAvenue Therapeutics, Inc. 17.38%13.510.0%$163.51m
SRPTSarepta Therapeutics, Inc. -1.05%108.7912.4%$135.30m

Company Profile

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.